Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ANIX — Anixa Biosciences Inc

CIK 1000275 TORONTO, A6
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,191
+$1,384 QoQ
Shares Held
1,497
+37.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 62 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. ANIX ranks #333 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in ANIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,191 1,497
2026-03-31 $2,807 1,088
2025-12-31 $4,449 1,426
2025-09-30 $3,300 1,000
2025-06-30 $3,300 1,000
2025-03-31 $2,860 1,000
2024-12-31 $2,320 1,000
2024-09-30 $3,150 1,000
2024-06-30 $3,155 1,428
2024-03-31 $3,120 1,000
2023-12-31 $4,473 1,153
2023-09-30 $3,658 1,119
2023-06-30 $4,172 1,304
2023-03-31 $4,424 1,029
2022-12-31 $4,373 1,029
2022-09-30 $4,974 1,011
2022-06-30 $3,060 1,000
2022-03-31 $2,740 1,000
2021-12-31 $2,970 1,000
2021-09-30 $4,770 1,000
2021-06-30 $7,760 2,000
2021-03-31 $18,720 4,000
2020-12-31 $6,140 2,000
2020-09-30 $3,066 1,262
2020-06-30 $3,858 1,261
2020-03-31 $352 222